USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $6.00-9.00 / Gram
USD $6.00-9.00 / Gram
USD $14.60-15.00 / Metric Ton
USD $6.00-9.00 / Gram
imatinib mesylate basic information |
product name: | imatinib mesylate |
synonyms: | glivec;gleevec;imatinib methanesulfonate;cgp-57148b;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;sti-571;imatinib base(ima-3) |
cas: | 220127-57-1 |
mf: | c30h35n7o4s |
mw: | 589.71 |
einecs: | |
product categories: | active pharmaceutical ingredients;intermediates & fine chemicals;pharmaceuticals;tyrosine kinase inhibitors;aromatics;heterocycles;api;glivec, cgp-57148b, sti-571;antineoplastic;anti-cancer&immunity;inhibitors |
mol file: | 220127-57-1.mol |
imatinib mesylate chemical properties |
mp | 214-224°c |
storage temp. | -20°c freezer |
cas database reference | 220127-57-1(cas database reference) |
safety information |
hazard codes | xn |
risk statements | 22 |
hazardous substances data | 220127-57-1(hazardous substances data) |
imatinib mesylate usage and synthesis |
a small-molecule inhibitor |
imatinib mesylate (also called gleevec) is a small-molecule inhibitor of the fusion protein bcr-abl, the causal agent in chronic myelogenous leukemia. as an inhibitor of pdgfr, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. imatinib has been reported to be an effective treatment for fip1l1-pdgfralpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans. |
chemical properties | off-white solid |
usage | a tyrosine kinase inhibitor. highly specific for bcr-abl, the enzyme associated with chronic myelogenous leukemia (cml) and certain forms of acute lymphoblastic leukemia (all) |
usage | imatinib mesylate is orally bioavailability mesylate salt of imatinib, which is a multi-target inhibitor of v-abl, c-kit and pdgfr with ic50 of 0.6 μm, 0.1 μm and 0.1 μm, respectively. imatinib also known as gleevec, glivec, cgp-57148b, sti-571 & imatinib |
usage | imatinib mesylate (sti571) is an orally bioavailability mesylate salt of imatinib, which is a multi-target inhibitor of v-abl, c-kit and pdgfr with ic50 of 0.6 μm, 0.1 μm and 0.1 μm, respectively. |
usage | echinocandin antifungal, active against infections with aspergillus and candida, inhibits cell wall synthesis |
service we provide:
1. mixed container, we can mix different items in one container.
2. quality control, before shipment, free sample for test. after shipment, keep sample for 3 years
3. prompt shipment with professional documents
4. packing as your request, with photo before shipment
we have clients throughout the world:
professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet your desire.
our laboratoy
we have our own independent lab test center:
this makes sure that our technology support is reliable and authoritative.all of self-owned fine chemicals are manufactured strictly in accordance with international standard.,and also has scientific cooperation with local colleges and institutes.
our factory
high quality with competitive price:
we are manufacturer and can provide high quality products with factory price
package & shipment
fast and safe delivery:
parcels can be sent out within 24 hours after payment. tracking number is available
secure and discreet shipment. you have various choices of transportation methods